Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the Brain

REFERENCES

• Anderson , J. A. and Kimmelman , J. 2010 . Extending clinical equipoise to phase 1 trials involving patients: Unresolved problems . Kennedy Institute of Ethics Journal , 20 ( 1 ) : 75 – 98 .
   PubMed Web of Science ®Google Scholar
• Bachoud-Lévi , A. C. , Gaura , V. Brugières , P. 2006 . Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long-term follow-up study . Lancet Neurology , 5 ( 4 ) : 303 – 309 .
   PubMed Web of Science ®Google Scholar
• Bezard , E. 2006 . A call for clinically driven experimental design in assessing neuroprotection in experimental Parkinsonism . Behavioural Pharmacology , 17 ( 5–6 ) : 379 – 382 .
   PubMed Web of Science ®Google Scholar
• Boucherie , C. and Hermans , E. 2009 . Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement? . Journal of Neuroscience Research , 87 ( 7 ) : 1509 – 1521 .
   PubMed Web of Science ®Google Scholar
• Carter , A. , Bartlett , P. and Hall , W. 2009 . Scare-mongering and the anticipatory ethics of experimental technologies . American Journal of Bioethics , 9 ( 5 ) : 47 – 48 .
   PubMed Web of Science ®Google Scholar
• Council for International Organizations of Medical Sciences . 2002 . International ethical guidelines for biomedical research involving human subjects , Geneva , , Switzerland : CIOMS .
   Google Scholar
• Daugherty , C. , Ratain , M. J. Grochowski , E. 1995 . Perceptions of cancer patients and their physicians involved in phase I trials . Journal of Clinical Oncology , 13 ( 5 ) : 1062 – 1072 .
   PubMed Web of Science ®Google Scholar
• Daugherty , C. K. , Ratain , M. J. Minami , H. 1998 . Study of cohort-specific consent and patient control in phase I cancer trials . Journal of Clinical Oncology , 16 ( 7 ) : 2305 – 2301 .
   PubMed Web of Science ®Google Scholar
• Dunnet , B. and Rosser , A. E. 2007 . Cell transplantation for Huntington's disease. Should we continue? . Brain Research Bulletin , 72 : 132 – 147 .
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research . 1995 . Guidance for industry content and format of investigational new drug applications (INDs) for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products , Rockville , MD : FDA .
   Google Scholar
• Food and Drug Administration . 1997 . International Conference on Harmonization; Guidance on general considerations for clinical trials . Federal Register , 62 : 66113 – 66119 .
   Google Scholar
• Freed , C. R. , Greene , P. E. Breeze , R. E. 2001 . Transplantation of embryonic dopamine neurons for severe Parkinson's disease . New England Journal of Medicine , 344 ( 10 ) : 710 – 719 .
   PubMed Web of Science ®Google Scholar
• Goebel , H. H. and Wisniewski , K. E. 2004 . Current state of clinical and morphological features in human NCL . Brain Pathology , 14 : 61 – 69 .
   PubMed Web of Science ®Google Scholar
• Grunwell , J. , Illes , J. and Karkazis , K. 2008 . Advancing neurodegenerative medicine: A call for expanded collaboration between scientists and ethicists . Neuroethics , 2 ( 1 ) : 13 – 20 .
   Web of Science ®Google Scholar
• Guillaume , D. J. and Zhang , S. C. 2008 . Human embryonic stem cells: A potential source of transplantable neural progenitor cells . Neurosurgical Focus , 24 ( 3–4 ) : 1 – 7 .
   Google Scholar
• Guillaume , D. J. , Huhn , S. L. Selden , N. R. 2008 . Cellular therapy for childhood neurodegenerative disease. Part I: Rationale and preclinical studies . Neurosurgical Focus , 24 ( 3–4 ) : E22
   PubMed Web of Science ®Google Scholar
• Henderson , G. E. , Churchill , L. R. Davis , A. M. 2007 . Clinical trials and medical care: defining the therapeutic misconception . PLoS Medicine , 4 ( 11 ) : e324
   PubMed Web of Science ®Google Scholar
• Horstmann , E. , McCabe , M. S. Grochow , L. 2005 . Risks and benefits of phase 1 oncology trials, 1991 through 2002 . New England Journal of Medicine , 352 ( 9 ) : 895 – 904 .
   PubMed Web of Science ®Google Scholar
• Joffe , S. and Miller , F. G. 2008 . Bench to bedside: Mapping the moral terrain of clinical research . Hastings Center Report , 38 ( 2 ) : 30 – 42 .
   PubMed Web of Science ®Google Scholar
• Kim , S. Y. , Appelbaum , P. S. Jeste , D. V. 2004 . Proxy and surrogate consent in geriatric neuropsychiatric research: Update and recommendations . American Journal of Psychiatry , 161 ( 5 ) : 797 – 806 .
   PubMed Web of Science ®Google Scholar
• Kimmelman , J. 2007 . The therapeutic misconception at 25: Treatment, research, and confusion . Hastings Center Report , 37 ( 6 ) : 36 – 42 .
   PubMed Web of Science ®Google Scholar
• Kimmelman , J. 2009 . Gene transfer and the ethics of first-in-human experiments: Lost in translation , New York , NY : Cambridge University Press .
   Google Scholar
• Kimmelman , J. , London , A. J. Ravina , B. 2009 . Launching invasive, first-in-human trials against Parkinson's disease: Ethical considerations . Movement Disorders , 24 ( 13 ) : 1893 – 1901 .
   PubMed Web of Science ®Google Scholar
• King , N. M. 2000 . Defining and describing benefit appropriately in clinical trials . Journal of Law, Medicine and Ethics , 28 ( 4 ) : 332 – 343 .
   PubMed Web of Science ®Google Scholar
• Kopelman , L. M. and Murphy , T. F. 2004 . Ethical concerns about federal approval of risky pediatric studies . Pediatrics , 113 ( 6 ) : 1783 – 1789 .
   PubMed Web of Science ®Google Scholar
• Lindvall , O. and Björklund , A. 2004 . Cell therapy in Parkinson's disease . NeuroRx , 4 : 382 – 393 .
   Google Scholar
• Lindvall , O. and Kokaia , Z. 2010 . Stem cells in human neurodegenerative disorders—Time for clinical translation? . Journal of Clinical Investigation , 120 ( 1 ) : 29 – 40 .
   PubMed Web of Science ®Google Scholar
• Lowenstein , P. R. 2008 . Clinical trials in gene therapy: ethics of informed consent and the future of experimental medicine . Current Opinion in Molecular Therapeutics , 10 ( 5 ) : 428 – 430 .
   PubMed Web of Science ®Google Scholar
• Magnus , D. 2010 . Translating stem cell research: Challenges at the research frontier . Journal of Law, Medicine, and Ethics , 38 ( 2 ) : 267 – 276 .
   PubMed Web of Science ®Google Scholar
• Martin , R. A. and Robert , J. S. 2007 . Is risky pediatric research without prospect of direct benefit ever justified? . American Journal of Bioethics , 7 ( 3 ) : 12 – 15 .
   PubMed Web of Science ®Google Scholar
• Master , Z. , McLeod , M. and Mendez , I. 2007 . Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease . Journal of Medical Ethics , 33 ( 3 ) : 169 – 173 .
   PubMed Web of Science ®Google Scholar
• Mathews , D. J. , Sugarman , J. Bok , H. 2008 . Cell-based interventions for neurologic conditions: ethical challenges for early human trials . Neurology , 71 ( 4 ) : 288 – 293 .
   PubMed Web of Science ®Google Scholar
• Miller , M. 2000 . Phase I cancer trials. A collusion of misunderstanding . Hastings Center Report , 4 : 34 – 43 .
   Google Scholar
• Miller , P. B. and Weijer , C. 2007 . Equipoise and the duty of care in clinical research: A philosophical response to our critics . Journal of Medicine and Philosophy , 32 ( 2 ) : 117 – 133 .
   PubMed Web of Science ®Google Scholar
• National Institutes of Health . 1998 . Policy and guidelines on the inclusion of children as participants in research involving human subjects , Bethesda , MD : NIH .
   Google Scholar
• Neuralstem . 2009 . Neuralstem receives FDA approval to commence first ALS stem cell trial Available at: http://www.neuralstem.com/index.asp?pgid = 42 (accessed November 26, 2010)
   Google Scholar
• Nurgat , Z. A. , Craig , W. Campbell , N. C. 2005 . Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy . British Journal of Cancer , 92 ( 6 ) : 1001 – 1005 .
   PubMed Web of Science ®Google Scholar
• Olanow , C. W. , Goetz , C. G. Kordower , J. H. 2003 . A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease . Annals of Neurology , 54 ( 3 ) : 403 – 414 .
   PubMed Web of Science ®Google Scholar
• Oberman , M. and Frader , J. 2003 . Dying children and medical research: access to clinical trials as benefit and burden . American Journal of Law and Medicine , 29 ( 2–3 ) : 301 – 317 .
   PubMed Web of Science ®Google Scholar
• Patoine , B. 2009 . Stem cell treatment for brain disorder appears safe, but efficacy still unknown. Available at: http://www.dana.org/news/features/detail.aspx?id = 22836
   Google Scholar
• Regenberg , A. , Mathews , D. J. Blass , D. M. 2009 . The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions . Journal of Cerebral Blood Flow and Metabolism , 29 ( 1 ) : 1 – 9 .
   PubMed Web of Science ®Google Scholar
• Resnik , D. B. and Miller , F. 2010 . The ethics of sham surgery on research subjects with cognitive impairments that affect decision-making capacity . Contemporary Clinical Trials , 31 ( 5 ) : 407 – 410 .
   PubMed Web of Science ®Google Scholar
• Ross , L. 2006 . Phase I research and the meaning of direct benefit . Journal of Pediatrics , 149 ( 1 suppl. ) : S20 – S24 .
   Web of Science ®Google Scholar
• Shah , S. , Whittle , A. Wilfond , B. 2004 . How do institutional review boards apply the federal risk and benefit standards for pediatric research? . Journal of the American Medical Association , 291 ( 4 ) : 476 – 482 .
   PubMed Web of Science ®Google Scholar
• Scheffer , I. E. , Baraitser , M. Wilson , J. 1991 . Pelizaeus– Merzbacher disease: Classical or connatal? . Neuropediatrics , 22 ( 2 ) : 71 – 78 .
   PubMed Web of Science ®Google Scholar
• Schwartz , P. H. and Kalichman , M. W. 2009 . Ethical challenges to cell-based interventions for the central nervous system: some recommendations for clinical trials and practice . American Journal of Bioethics , 9 ( 5 ) : 41 – 43 .
   PubMed Web of Science ®Google Scholar
• Selden , N. R. , Guillaume , D. J. Steiner , R. D. 2008 . Cellular therapy for childhood neurodegenerative disease. Part II: Clinical trial design and implementation . Neurosurgical Focus , 24 ( 3–4 ) : E23
   PubMed Web of Science ®Google Scholar
• Selden , N. R. , Guillaume , D. J. Steiner , R. D. 2008 . Cellular therapy for childhood neurodegenerative disease. Part II: Clinical trial design and implementation . Neurosurgical Focus , 24 ( 3–4 ) : E23
   PubMed Web of Science ®Google Scholar
• Sondhi , D. , Hackett , N. R. Peterson , D. A. 2007 . Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh10 rhesus macaque-derived adeno-associated virus vector . Molecular Therapy , 15 ( 3 ) : 481 – 491 .
   PubMed Web of Science ®Google Scholar
• StemCells, Inc. 2009 . StemCells, Inc. announces positive phase 1 Batten trial results . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1297008&high light= (accessed November 26, 2010)
   Google Scholar
• StemCells, Inc. 2010a . StemCells, Inc. announces first human neural stem cell transplant in landmark myelination disorder trial . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle_print&ID=1386091& highlight = (accessed November 26, 2010)
   Google Scholar
• StemCells, Inc. 2010b . StemCells, Inc. reports progress in myelination disorder trial . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1480189 &highlight = (accessed November 26, 2010)
   Google Scholar
• StemCells, Inc. 2010c . StemCells, Inc. plans to advance to second clinical trial in Batten disease . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle &ID = 1415661&highlight = (accessed November 26, 2010)
   Google Scholar
• Stemcells, Inc. 2010d . StemCells, Inc. advances to second clinical trial in Batten disease . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1488590 &highlight= (accessed November 26, 2010)
   Google Scholar
• StemCells, Inc. 2010e . StemCells, Inc.'s phase I Batten trial data featured at American Association of Neurological Surgeons Annual Meeting . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1421146&high light=
   Google Scholar
• StemCells, Inc. 2011a . StemCells, Inc. discontinues Batten disease program . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1488590& highlight= (accessed April 2, 2011)
   Google Scholar
• StemCells, Inc. 2011b . StemCells, Inc. completes dosing in second trial of HuCNS-SC(R) neural stem cells . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p= irol-newsArticle&ID=1530091&highlight= (accessed May 2, 2011)
   Google Scholar
• StemCells, Inc. 2012a . StemCells, Inc's Milestone Clinical Trial in Pelizaeus-Merzbacher Disease Shows Evidence of Myelination Following Human Neural Stem Cell Transplantation . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1678880&highlight= (accessed April 2, 2012)
   Google Scholar
• StemCells, Inc. 2012b . StemCells, Inc. to Discuss Pelizaeus-Merzbacher Disease Phase I Clinical Trial Results Conference Call . Available at: http://investor.stemcellsinc.com/phoenix.zhtml?p=irol-eventDetails&c=86230&eventID=4746221 (accessed April 2, 2012)
   Google Scholar
• Tamaki , S. J. , Jacobs , Y. Dohse , M. 2009 . Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis . Cell Stem Cell , 5 ( 3 ) : 310 – 319 .
   PubMed Web of Science ®Google Scholar
• Trapp , B. D. 2008 . Rescue of congenital hypomyelination by progenitor cell transplantation . Cell Stem Cell , 2 ( 6 ) : 519 – 520 .
   PubMed Web of Science ®Google Scholar
• Uchida , N. 2008 . Translating human CNS stem cells to clinic: Neuroprotection , Philadelphia : 6th ISSCR Annual Meeting . June 11–14
   Google Scholar
• Valeo , T. 2006 . Clinical trials for neural stem cells approved for Batten disease . Neurology Today , 6 ( 28 ) : 1 – 12 .
   PubMedGoogle Scholar
• Weijer , C. and Miller , P. B. 2004 . When are research risks reasonable in relation to anticipated benefits? . Nature Medicine , 10 ( 6 ) : 570 – 573 .
   PubMed Web of Science ®Google Scholar
• Weijer , C. and Miller , P. B. 2007 . Refuting the net risks test: A response to Wendler and Miller's “Assessing research risks systematically . Journal of Medicine and Ethics , 33 ( 8 ) : 487 – 490 .
   PubMed Web of Science ®Google Scholar
• Windrem , S. C. , Schanz , S. J. Guo , M. 2008 . Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse . Cell Stem Cell , 2 ( 6 ) : 553 – 565 .
   PubMed Web of Science ®Google Scholar
• Worgall , S. , Sondhi , D. Hackett , N. R. 2008 . Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA . Human Gene Therapy , 19 ( 5 ) : 463 – 474 .
   PubMed Web of Science ®Google Scholar
• World Medical Association . 2008 . WMA declaration of Helsinki—Ethical principles for medical research involving human subjects 2008 , Seoul : 59th WMA General Assembly . October
   Google Scholar